Today the TGA announced a final decision to down-schedule certain low dose cannabidiol preparations from Schedule 4 (Prescription Medicine) to Schedule 3 (Pharmacist Only Medicine).
The decision allows low-dose CBD containing products, up to a maximum of 150 mg/day, for use in adults that have been pre-approved by the TGA, to be supplied over-the-counter by a Pharmacist without a prescription provided certain controls are followed. Please read today's member alert for more information, including:
- The summary effect of the decision for the public
- A full overview of the scheduling decision
- Information for sponsors interested in pursuing clinical research and registration applications